首页|可溶性髓样细胞触发受体-1和组织金属蛋白酶抑制剂3水平与糖尿病肾病严重程度及预后的关系

可溶性髓样细胞触发受体-1和组织金属蛋白酶抑制剂3水平与糖尿病肾病严重程度及预后的关系

扫码查看
目的 观察糖尿病肾病(DN)患者血清可溶性髓样细胞触发受体-1(sTREM-1)、组织金属蛋白酶抑制剂3(TIMP3)水平变化,探讨其与DN患者病情严重程度及预后的关系.方法 2018年1月-2020年12月西安交通大学第一附属医院诊治DN患者130例(DN组)、单纯2型糖尿病(T2DM)患者80例(T2DM组),同期健康体检者80例(对照组),均采用ELISA法检测血清sTREM-1、TIMP3水平.DN组患者根据估算肾小球滤过率(eGFR)分为G1期组[eGFR≥90 mL/(min·1.73 m2)]31 例,G2 期组[eGFR 60~<90 mL/(min·1.73 m2)]18 例,G3 期组[eGFR 30~<60 mL/(min·1.73 m2)]25 例,G4 期组[eGFR 15~<30 mL/(min·1.73 m2)]56 例,比较 4 组血清 sTREM-1、TIMP3水平.随访3年,DN患者根据预后分为预后不良组39例和预后良好组91例,比较2组年龄及血清sTREM-1、TIMP3水平等临床资料.采用Spearman相关法分析DN患者eGFR与血清sTREM-1、TIMP3水平的相关性;采用多因素Cox回归分析DN患者预后不良的影响因素;绘制ROC曲线,评估血清sTREM-1、TIMP3预测DN患者预后不良的效能.结果 对照组、T2DM 组、DN 组血清 sTREM-1[(71.45±19.34)、(101.24±24.83)、(138.21±33.68)ng/L]、TIMP3[(968.99±187.77)、(862.21±202.93)、(671.55±160.55)ng/L]水平比较差异均有统计学意义(F=146.005,P<0.001;F=72.384,P<0.001),其中血清 sTREM-1 水平依次升高(P<0.05),TIMP3 水平依次降低(P<0.05).G1期组、G2 期组、G3 期组、G4 期组血清 sTREM-1[(94.41±16.93)、(125.59±14.71)、(138.62±11.68)、(166.33±20.95)ng/L]、TIMP3[(858.87±81.85)、(765.05±64.48)、(696.16±30.38)、(526.82±103.85)ng/L]水平比较差异均有统计学意义(F=112.836,P<0.001;F=114.064,P<0.001),其中血清 sTREM-1 水平依次升高(P<0.05),TIMP3水平依次降低(P<0.05).DN患者eGFR与血清sTREM-1水平呈正相关(r=0.787,P<0.001),与血清TIMP3水平呈负相关(r=-0.796,P<0.001).随访(2.53±0.36)年,130例DN患者预后不良发生率为30.00%.预后不良组年龄[(62.62±11.11)岁]大于预后良好组[(58.20±11.40)岁](t=2.039,P=0.043),高血压比率(35.90%)及糖化血红蛋白[8.07%(7.37%,9.48%)]、血尿酸[(393.23±66.97)mmol/L]、血肌酐[185.76(158.48,212.46)μmol/L]、sTREM-1[(163.12±27.16)ng/L]水平均高于预后良好组[13.19%、7.43%(6.68%,8.41%)、(358.11±80.68)mmol/L、159.12(133.67,189.54)μmol/L、(127.54±30.50)ng/L](x2=8.800,U=3.480,t=2.388,U=2.949,t=6.293,P 均<0.05),eGFR[21.80(17.13,39.62)mL/(min·1.73 m2)]及白蛋白[(31.62±7.05)g/L]、TIMP3[(550.49±155.35)ng/L]水平均低于预后良好组[60.36(23.36,95.46)mL/(min·1.73 m2)、(34.41±5.19)g/L、(723.44±133.14)ng/L](U=5.108,P<0.001;t=2.227,P=0.030;t=6.450,P<0.001).高血压(HR=3.587,95%CI:1.110~11.589,P=0.033)、糖化血红蛋白(HR=2.801,95%CI:1.383~5.671,P=0.004)、eGFR(HR=0.956,95%CI:0.928~0.985,P=0.003)、sTREM-1(HR=1.047,95%CI:1.020~1.074,P=0.001)、TIMP3(HR=0.992,95%CI:0.987~0.996,P=0.001)是DN患者预后不良的影响因素.血清sTREM-1、TIMP3分别以132.67、606.51 ng/L为最佳截断值,二者单独及联合预测 DN 患者预后不良的AUC 分别为 0.793(95%CI:0.713~0.859,P<0.001)、0.796(95%CI:0.717~0.862,P<0.001)、0.875(95%CI:0.806~0.927,P<0.001),灵敏度分别为 89.74%、66.67%、79.49%,特异度分别为53.85%、81.32%、87.91%;二者联合预测DN患者预后不良的AUC大于sTREM-1、TIMP3单独预测(Z=2.767,P=0.007;Z=2.763,P=0.006).结论 随病情严重程度加重,DN患者血清sTREM-1水平升高,TIMP3水平降低;有高血压、sTREM-1和糖化血红蛋白升高、eGFR和TIMP3水平降低的DN患者预后不良风险较大;血清sTREM-1、TIMP3联合预测DN患者预后不良的价值较高.
Relationships of soluble triggering receptor expressed on myeloid cell-1 and tissue inhibitor of metalloproteinase 3 levels with the severity and prognosis of diabetic nephropathy
Objective To observe the changes of serum soluble triggering receptor expressed on myeloid cell-1(sTREM-1)and tissue inhibitor of metalloproteinase 3(TIMP3)levels in patients with diabetic nephropathy(DN),and to investigate their relationships with the disease severity and prognosis of DN patients.Methods From January 2018 to December 2020,130 DN patients(DN group),80 type 2 diabetes mellitus(T2DM)patients(T2DM group),and 80 healthy controls(control group)in the First Affiliated Hospital of Xi'an Jiaotong University were detected the serum sTREM-1 and TIMP3 levels using ELISA.Based on estimated glomerular filtration rate(eGFR),DN patients were categorized into G1[eGFR:≥90 mL/(min·1.73 m2),n=31],G2[eGFR:60 to<90 mL/(min·1.73 m2),n=18],G3[eGFR:30 to<60 mL/(min·1.73 m2),n=25],and G4[eGFR:15 to<30 mL/(min·1.73 m2),n=56]stages.The serum sTREM-1 and TIMP3 levels were compared among DN,T2DM and control groups,and across G1 to G4 stages.DN patients were divided into poor prognosis group(n=39)and good prognosis group(n=91)based on the three-year follow-up results,and the clinical data as age and serum sTREM-1 and TIMP3 levels were compared between two groups.The correlations of eGFR with serum sTREM-1 and TIMP3 levels were analyzed using Spearman's method.Multivariate Cox regression was used to analyze the influencing factors of poor prognosis of DN patients.ROC curves were plotted to evaluate the efficiencies of serum sTREM-1 and TIMP3 levels on predicting poor prognosis of DN patients.Results Significant differences were found in serum sTREM-1[(71.45±19.34),(101.24±24.83),(138.21±33.68)ng/L]and TIMP3 levels[(968.99±187.77),(862.21±202.93),(671.55±160.55)ng/L]among control,T2DM and DN groups(F=146.005,P<0.001;F=72.384,P<0.001),with serum sTREM-1 levels increasing(P<0.05),and TIMP3 levels decreasing sequentially(P<0.05).Significant differences were also observed in serum sTREM-1[(94.41±16.93),(125.59±14.71),(138.62±11.68),(166.33±20.95)ng/L]and TIMP3 levels[(858.87±81.85),(765.05±64.48),(696.16±30.38),(526.82±103.85)ng/L]from G1to G4 stages(F=112.836,P<0.001;F=114.064,P<0.001),with sTREM-1 levels increasing(P<0.05),and TIMP3 levels decreasing sequentially(P<0.05).The eGFR was positively correlated with serum sTREM-1 level(r=0.787,P<0.001),and was negatively correlated with TIMP3 level in DN patients(r=-0.796,P<0.001).At a follow-up of(2.53±0.36)years,the poor prognosis rate was 30.00%in 130 DN patients.The age was older in poor prognosis group[(62.62±11.11)years]than in good prognosis group[(58.20±11.40)years](t=2.039,P=0.043).The rate of hypertension,and the levels of glycosylated hemoglobin,blood uric acid,blood creatinine and sTREM-1 were higher in poor prognosis group[35.90%,8.07%(7.37%,9.48%),(393.23±66.97)mmol/L,185.76(158.48,212.46)μmol/L,(163.12±27.16)ng/L]than those in good prognosis group[13.19%,7.43%(6.68%,8.41%),(358.11±80.68)mmol/L,159.12(133.67,189.54)μmol/L,(127.54±30.50)ng/L](x2=8.800,U=3.480,t=2.388,U=2.949,t=6.293;all P values<0.05),while the eGFR and the levels of albumin and TIMP3 were lower in poor prognosis group[21.80(17.13,39.62)mL/(min·1.73 m2),(31.62±7.05)g/L,(550.49±155.35)ng/L]than those in good prognosis group[60.36(23.36,95.46)mL/(min·1.73 m2),(34.41±5.19)g/L,(723.44±133.14)ng/L](U=5.108,P<0.001;t=2.227,P=0.030;t=6.450,P<0.001).Hypertension(HR=3.587,95%CI:1.110-11.589,P=0.033),glycosylated hemoglobin(HR=2.801,95%CI:1.383-5.671,P=0.004),eGFR(HR=0.956,95%CI:0.928-0.985,P=0.003),sTREM-1(HR=1.047,95%CI:1.020-1.074,P=0.001),and TIMP3(HR=0.992,95%CI:0.987-0.996,P=0.001)were the influencing factors of poor prognosis of DN patients.When using the cut-off values of serum sTREM-1 and TIMP3 of 132.67 and 606.51 ng/L,the AUCs of serum sTREM-1,TIMP3,and their combination for predicting poor prognosis of DN patients were 0.793(95%CI:0.713-0.859,P<0.001),0.796(95%CI:0.717-0.862,P<0.001),and 0.875(95%CI:0.806-0.927,P<0.001),with the sensitivities of 89.74%,66.67%and 79.49%,and the specificities of 53.85%,81.32%and 87.91%,respectively.The AUC of their combination was greater than that of sTREM-1 and TIMP3 alone(Z=2.767,P=0.007;Z=2.763,P=0.006).Conclusions With the aggravation of disease severity,the serum sTREM-1 level increases and the TIMP 3 level decreases in DN patients.Those with hypertension,elevated levels of sTREM-1 and glycosylated hemoglobin,and reduced eGFR and TIMP3 level have a high risk of poor prognosis,and the combined detection of serum sTREM-1 and TIMP3 levels has a high value to the prediction of poor prognosis of DN patients.

diabetic nephropathysoluble triggering receptor expressed on myeloid cell-1tissue inhibitor of metalloproteinase 3severity of disease

赵珊、尹晶晶、李微、陈谱

展开 >

西安交通大学第一附属医院检验科,陕西西安 710061

榆林市第一医院输血检验科,陕西榆林 719000

西安交通大学第一附属医院内分泌科,陕西西安 710061

糖尿病肾病 可溶性髓样细胞触发受体-1 组织金属蛋白酶抑制剂3 病情严重程度

陕西省自然科学基础研究计划项目

2022JM-609

2024

中华实用诊断与治疗杂志
中华预防医学会 河南省人民医院

中华实用诊断与治疗杂志

CSTPCD
影响因子:1.276
ISSN:1674-3474
年,卷(期):2024.38(9)
  • 14